Text: H.R.5418 — 115th Congress (2017-2018)All Information (Except Text)

Text available as:

Shown Here:
Referred in Senate (05/22/2018)


115th CONGRESS
2d Session
H. R. 5418


IN THE SENATE OF THE UNITED STATES

May 22, 2018

Received; read twice and referred to the Committee on Veterans' Affairs


AN ACT

To direct the Secretary of Veterans Affairs to carry out the Medical Surgical Prime Vendor program using multiple prime vendors.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Veterans Affairs Medical-Surgical Purchasing Stabilization Act”.

SEC. 2. Medical Surgical Prime Vendor program.

(a) Vendors.—In procuring certain medical, surgical, and dental supplies or laboratory supplies for medical centers of the Department of Veterans Affairs, the Secretary of Veterans Affairs shall carry out the Medical Surgical Prime Vendor program, or successor program, in a manner that—

(1) requires the Secretary to award contracts to multiple regional prime vendors instead of a single nationwide prime vendor; and

(2) prohibits a prime vendor from solely designing the formulary of such supplies.

(b) Clinically driven sourcing.—

(1) EXPERTISE.—In carrying out the formulary of supplies under the Medical Surgical Prime Vendor program, or successor program, the Secretary shall ensure that each employee of the Department of Veterans Affairs who conducts formulary analyses or makes decisions with respect to including items on the formulary has medical expertise relevant to the items for which the employee conducts such analyses or makes such decisions.

(2) LISTS.—Not later than 30 days after the date of the enactment of this Act, and quarterly thereafter with respect to any updates, the Secretary shall submit to the Committees on Veterans’ Affairs of the House of Representatives and the Senate a list of each employee described in paragraph (1) and the relevant medical expertise of the employee, listed by the categories of items in the formulary described in such paragraph.

Passed the House of Representatives May 21, 2018.

    Attest: karen l. haas,   
    Clerk